Reported 0 shares, down 71,636 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 753000 |
| 2022-03-31 | 262000 |
| 2022-06-30 | 43000 |
| 2022-09-30 | 55000 |
| 2022-12-31 | 38212 |
| 2023-03-31 | 98072 |
| 2023-06-30 | 1388214 |
| 2023-09-30 | 1660352 |
| 2023-12-31 | 395888 |
| 2024-03-31 | 410734 |
| 2024-06-30 | 108170 |
| 2024-09-30 | 121781 |
| 2024-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2024 | Reduced | 0 | -71,636 (-100.0%) | 0 | $0 | 2025-02-14 | |
| Q3 2024 | Unchanged | 71,636 | 0 (0.0%) | < 0.01% | $121,781 | 2024-11-14 | |
| Q2 2024 | Reduced | 71,636 | -175,794 (-71.0%) | < 0.01% | $108,170 | 2024-08-14 | |
| Q1 2024 | Unchanged | 247,430 | 0 (0.0%) | < 0.01% | $410,734 | 2024-05-15 | |
| Q4 2023 | Added | 247,430 | +29,393 (13.5%) | < 0.01% | $395,888 | 2024-02-14 | |
| Q3 2023 | Added | 218,037 | +6,419 (3.0%) | < 0.01% | $1,660,352 | 2023-11-14 | |
| Q2 2023 | Added | 211,618 | +195,218 (1190.4%) | < 0.01% | $1,388,214 | 2023-08-14 | |
| Q1 2023 | Unchanged | 16,400 | 0 (0.0%) | < 0.01% | $98,072 | 2023-05-15 | |
| Q4 2022 | Unchanged | 16,400 | 0 (0.0%) | < 0.01% | $38,212 | 2023-02-14 | |
| Q3 2022 | Unchanged | 16,400 | 0 (0.0%) | < 0.01% | $55,000 | 2022-11-15 | |
| Q2 2022 | Reduced | 16,400 | -72,853 (-81.6%) | < 0.01% | $43,000 | 2022-08-15 | |
| Q1 2022 | Added | 89,253 | +1,190 (1.4%) | < 0.01% | $262,000 | 2022-05-16 | |
| Q4 2021 | Added | 88,063 | +2,049 (2.4%) | < 0.01% | $753,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
50 managers reported RENEO PHARMACEUTICALS INC for Q4 2024.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| NEA Management Company LLC | Reduced | 0 | -4,785,494 | 0 | $0 | 15 qtrs |
| TANG CAPITAL MANAGEMENT LLC | Reduced | 0 | -2,946,260 | 0 | $0 | 5 qtrs |
| Barclays PLC | Reduced | 0 | -228 | 0 | $0 | 12 qtrs |
| AMERIPRISE FINANCIAL INC | Reduced | 0 | -49,824 | 0 | $0 | 2 qtrs |
| Shay Capital LLC | Reduced | 0 | -28,617 | 0 | $0 | 2 qtrs |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 0 | -501,534 | 0 | $0 | 11 qtrs |
| Carlyle Group Inc | Reduced | 0 | -2,698,957 | 0 | $0 | 8 qtrs |
| SIMPLEX TRADING LLC | Reduced | 0 | -100 | 0 | $0 | 2 qtrs |
| Russell Investments Group Ltd | Reduced | 0 | -9,520 | 0 | $0 | 4 qtrs |
| JPMorgan Chase & Co | Reduced | 0 | -7,668 | 0 | $0 | 15 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2024
- Filed
- February 14, 2025
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.